GlassScriptPhysician profile
Steven P Petrou
NPI 1982694782
$3,460.82
in general payments reported to CMS, 2019-2025
9 companies · $560 in 2025
The $560 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Urology) provider received nationally (typical 2025 total: $782).
See the full distribution for Urogynecology and Reconstructive Pelvic Surgery (Urology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $745 · 2020: $235 · 2021: $46.92 · 2022: $62.62 · 2023: $157 · 2024: $1,655 · 2025: $560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,190 · Travel and Lodging: $1,181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,190.20 |
| Travel and Lodging | $1,181.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals As | $1,240.31 | 2024 | Adstiladrin |
| Coloplast Corp | $723.84 | 2019-2025 | |
| Boston Scientific Corporation | $605.40 | 2019-2025 | Ams 700, General - Erectile Dysfunction, Ams 700 Cxr Rte Kit |
| Cook Medical LLC | $331.89 | 2019-2025 | Cook |
| Ambu INC. | $233.64 | 2023-2024 | |
| C. R. Bard, INC. & Subsidiaries | $159.10 | 2019 | |
| Telix Pharmaceuticals | $128.96 | 2024 | Illuccix |
| Urogen Pharma, INC. | $19.21 | 2024 | |
| Laborie Medical Technologies Corp. | $18.47 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Petrou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.